Zai Lab Ltd (ZLAB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

4560 JINKE ROAD SHANGHAI, CHINA 201210

Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

Data as of 2021-04-11 08:01:09 -0400
Market Cap11.75 Billion Shares Outstanding88.592 Million Avg 30-day Volume451.894 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.10398 52-week High/Low193.54 / 57.13 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from ZLAB instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 8 7 14.29% 7 (0.42%) 5 (0.31%) 40.0%
Funds Holding: 185 173 6.94% 52 (3.13%) 49 (3.05%) 6.12%
13F shares: 53.564 Million 49.383 Million 8.47% 14.49 Million 11.79 Million 22.9%
% Ownership 71.0633 65.5157 8.47% 19.2238 15.642 22.9%
New Positions: 33 27 22.22% 11 10 10.0%
Increased Positions 87 80 8.75% 23 18 27.78%
Closed Positions 20 22 -9.09% 8 11 -27.27%
Reduced Positions 41 40 2.5% 14 15 -6.67%
Total Calls 42.407 Thousand 88.001 Thousand -51.81% 7.5 Thousand 34.6 Thousand -78.32%
Total Puts 20.703 Thousand 85.9 Thousand -75.9% 5.8 Thousand 8.4 Thousand -30.95%
PUT/CALL Ratio 0.49 0.98 -50.0% 0.77 0.24 220.83%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ZLAB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZLAB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

115.4 Thousand total shares from 22 transactions

Exercise Derivative Conversion (M)

20 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DU YING CHAIRWOMAN & CEO

  • Officer
  • Director
897,541 2021-04-05 3

LIANG YI CCO & PRESIDENT, GREATER CHINA

  • Officer
23,650 2021-04-01 2

REINHART HARALD CHIEF MEDICAL OFFICER

  • Officer
31,700 2021-04-01 2

CHO WILLIAM KI CHUL CHIEF FINANCIAL OFFICER

  • Officer
28,650 2021-04-01 2

EDMONDSON FRAZOR TITUS III CHIEF LEGAL OFFICER

  • Officer
26,150 2021-04-01 2

SANDLER ALAN B. HEAD OF GLOBAL DEV., ONCOLOGY

  • Officer
33,300 2021-04-01 2

FU TAO PRESIDENT & COO

  • Officer
  • Director
794,500 2021-03-26 2

CHEN KAI-XIAN

  • Director
24,662 2021-03-12 3

WIRTH PETER

  • Director
338,852 2021-01-15 4

MOULDER LEON O JR

  • Director
13,852 2021-01-15 2

DIEKMAN JOHN D

  • Director
63,852 2021-01-15 2

LIS WILLIAM

  • Director
28,277 2021-01-15 2

LEUNG NISA

  • Director
9,072,932 2021-01-01 1

QIMING CORPORATE GP IV, LTD

QIMING GP IV, L.P.

QIMING VENTURE PARTNERS IV, L.P.

QIMING MANAGING DIRECTORS FUND IV, L.P.

QM 11 LTD

  • 10% Owner
9,072,932 2021-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-07 S 1,720 $131.83 d 917,180 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-07 S 10,369 $134.40 d 906,498 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-07 S 577 $130.34 d 918,900 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-07 S 940 $135.94 d 897,541 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-07 S 313 $133.12 d 916,867 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-07 S 8,017 $135.17 d 898,481 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 9,689 $128.38 d 920,961 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 860 $125.25 d 952,117 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 19,444 $127.55 d 930,650 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 3,614 $124.39 d 952,977 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 1,484 $129.21 d 919,477 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 2,023 $126.62 d 950,094 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-06 S 1,278 $123.20 d 956,591 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 589 $132.42 d 957,869 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 2,700 $128.65 d 960,767 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 20,494 $125.70 d 976,667 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 492 $131.09 d 958,458 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 4,510 $127.69 d 963,467 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 11,492 $124.63 d 997,161 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 1,817 $129.63 d 958,950 direct yes -0.1881 0.0 1 -0.1881 2

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-05 S 8,690 $126.45 d 967,977 direct yes -0.1881 0.0 1 -0.1881 2

CHO WILLIAM KI CHUL - Officer CHIEF FINANCIAL OFFICER

2021-04-05 21:41:09 -0400 2021-04-01 A 4,600 a 4,600 direct

SANDLER ALAN B. - Officer HEAD OF GLOBAL DEV., ONCOLOGY

2021-04-05 21:44:50 -0400 2021-04-01 A 28,000 a 28,000 direct

EDMONDSON FRAZOR TITUS III - Officer CHIEF LEGAL OFFICER

2021-04-05 21:49:39 -0400 2021-04-01 A 4,150 a 4,150 direct

LIANG YI - Officer CCO & PRESIDENT, GREATER CHINA

2021-04-05 21:53:56 -0400 2021-04-01 A 20,000 a 20,000 direct

CHO WILLIAM KI CHUL - Officer CHIEF FINANCIAL OFFICER

2021-04-05 21:41:09 -0400 2021-04-01 A 24,050 a 24,050 direct

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-05 21:46:05 -0400 2021-04-01 A 17,000 a 17,000 direct

EDMONDSON FRAZOR TITUS III - Officer CHIEF LEGAL OFFICER

2021-04-05 21:49:39 -0400 2021-04-01 A 22,000 a 22,000 direct

REINHART HARALD - Officer CHIEF MEDICAL OFFICER

2021-04-05 21:54:09 -0400 2021-04-01 A 5,050 a 5,050 direct

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-07 19:55:09 -0400 2021-04-01 G 16,000 d 1,008,653 direct -0.1881 0.0 1 -0.1881 2

SANDLER ALAN B. - Officer HEAD OF GLOBAL DEV., ONCOLOGY

2021-04-05 21:44:50 -0400 2021-04-01 A 5,300 a 5,300 direct

DU YING - Director - Officer CHAIRWOMAN & CEO

2021-04-05 21:46:05 -0400 2021-04-01 A 87,000 a 87,000 direct

LIANG YI - Officer CCO & PRESIDENT, GREATER CHINA

2021-04-05 21:53:56 -0400 2021-04-01 A 3,650 a 3,650 direct

REINHART HARALD - Officer CHIEF MEDICAL OFFICER

2021-04-05 21:54:09 -0400 2021-04-01 A 26,650 a 26,650 direct

FU TAO - Director - Officer PRESIDENT & COO

2021-03-30 18:48:40 -0400 2021-03-26 M 20,000 $18.92 a 207,000 direct yes -1.8512 -0.4122 1.3865 5 -6.2355 3

FU TAO - Director - Officer PRESIDENT & COO

2021-03-30 18:48:40 -0400 2021-03-26 M 20,000 d 480,000 direct yes

CHEN KAI-XIAN - Director

2021-03-30 20:51:57 -0400 2021-03-12 S 4,302 $142.53 d 24,662 direct -1.8512 -0.4122 1.3865 5 -6.2355 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ZAI LAB LTD-ADR ZLAB 2021-04-14 22:15:03 UTC -0.2235 0.2835 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 21:45:03 UTC -0.2255 0.2855 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 21:15:03 UTC -0.2255 0.2855 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 20:45:03 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 20:15:04 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 19:45:03 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 19:15:03 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 18:45:02 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 18:15:03 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 17:45:03 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 17:15:03 UTC -0.2144 0.2744 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 16:45:03 UTC -0.2043 0.2643 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 16:15:03 UTC -0.2043 0.2643 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 15:45:03 UTC -0.2043 0.2643 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 15:15:03 UTC -0.2043 0.2643 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 14:45:02 UTC -0.19 0.25 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 14:15:03 UTC -0.19 0.25 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 13:45:03 UTC -0.19 0.25 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 13:15:03 UTC -0.19 0.25 250000
ZAI LAB LTD-ADR ZLAB 2021-04-14 12:45:03 UTC -0.19 0.25 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments